Optimer Pharmaceuticals, Inc. today reported money results for the second quarter ended June 30, 2010. Optimer reported a net loss for the second quarter of 2010 of $10.4 million, or $0.27 per share, which was in line with the Company's expectations. This assort to a net loss for the second quarter of 2009 of $12.4 million, or $0.37 per share. The decrease in net loss was chiefly due to lower experimentation and turn


copyrights:cite this source synonym collection v1.1copyright © 2008 by lexico publishing group expenses offset by an upswing in general and central expenses.

More: - From the site